Introduction
Elimination of measles is defined as the absence of endemic measles cases in a country or region for ≥12 months while under adequate surveillance [1] [2] [3] . Measles has been successfully eliminated in the Americas [4] . All other World Health Organization (WHO) regions have set elimination goals for measles. In 2011, the WHO African Region (AFR) adopted a measles elimination goal to be reached by the end of 2020 [5] . Activities for measles control and elimination include routine immunization (RI), supplemental immunization activities (SIAs), case management, outbreak response, and surveillance [5] . RI builds protection against measles virus by providing two doses of a measles-containing vaccine (MCV) to infants aged 9-18 months [6] . SIAs are immunization campaigns targeting children in a defined age group in a specified geographical area. SIAs provide a second opportunity for measles immunization in children not reached by RI or those not seroconverting after routine immunization [7, 8] . "Catch-up" SIAs are usually the initial campaigns conducted, targeting children aged 9 months through 14 years, with the aim to achieve high population immunity quickly and interrupt measles transmission, while "follow-up" SIAs are conducted at regular intervals, usually 3-4 years, among children aged <5 years, to reduce accumulation of susceptible children [9] .
The WHO Africa Regional Office (AFRO) has established measles elimination indicators, including: 1) measles incidence <1 case per million population at national level; 2) ≥95% MCV1 coverage in RI at national and at sub-national levels; 3) 95% coverage in measles SIAs and outbreak response immunization activities (ORI); 4) ≥80% of districts (sub-national levels) investigating one or more suspected measles cases within a year; and 5) reported non-measles febrile rash illness rate of ≥2 per 100,000 population at national level [5] .
In Kenya, the Expanded Program on Immunization (EPI) was started in 1980 with the first dose of measles-containing vaccine (MCV) or MCV1 given at 9 months of age. Accelerated control for measles was started in 2002 when the first catch-up SIA that targeted children aged 9 months to 14 years was conducted, followed by periodic SIAs and the establishment of a case-based surveillance for measles with laboratory confirmation. In addition, 
Methods
We conducted a review of RI data, SIAs data and the Kenya Case-based surveillance indicators: During the study period, the national non-measles febrile rash illness (NMFRI) reporting rate was ≥2 cases per 100,000 persons all 14 years, and the proportion of counties investigating >one suspect case per year was ≥80% in all but 3 years (Table 1) . A high proportion of suspected measles cases were investigated with collection of an adequate serum specimen for laboratory testing. However, there was delay in transportation of collected samples to the laboratory within the targeted period (≤3 days), and there was delay in reporting of laboratory results to the sub-national levels ( Table 1) . The proportion of discarded cases remained constant over the years including the years with outbreaks ( Figure 2) . The overall incidence for the 14-year period was >5 cases/million; annual incidence ranged from 2-65 cases/million persons (Table 2, Figure 2 ). There were no significant differences in measles incidence by gender. The highest incidence rates occurred among infants aged <1 year This finding is consistent with findings in Nigeria and Democratic Republic Of Congo, where outbreaks have been observed due to sub-optimal coverage in MCV and SIA [13, 14] and in Zambia, where after a successful SIA a resurgence of cases was observed after 3 years [15] . Experience from the United States indicate that coverage of >90% with two MCV doses are required to end transmission of measles [16] . contributed to low uptake of MCV2. The low uptake in MCV2 was also observed in the initial years after introduction in the United republic of Tanzania [17] . Interventions such as sending out text message reminders to mothers can be used to improve the uptake [18, 19] . In addition, health workers at the immunization service 
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Conclusion
In conclusion, although there is evidence of progress towards elimination of measles in the country, the relatively stagnant MCV1 coverage and the low uptake of MCV2 could reverse these trends.
Efforts to improve MCV1 coverage, strengthen MCV2 uptake, and target high-risk areas (age groups and counties with the higher incidence) need to be put in place. In addition, the Kenya [1] IR is Incidence Rate, calculated by dividing the number of confirmed cases by population estimate for the year and multiplied by 1,000,000 2 Confirmed cases include laboratory-confirmed, epidemiologically confirmed and clinical-compatible case 3 Vaccination status data on parentheses is percentage 
